NYSE : AFT
-$0.05 (-0.34%)
NYSE
Joseph Moroney CFA
Asset Management
Financial Services
AFT
N/A
US
USD
212-515-3200
037636107
0001502573
0.55
6.08
6.08
5.65
0.64
$32.82M
7.05
0.99
10.22
1.45
$2.31
$35.96M
109.58%
109.58%
15.80%
9.70%
6.43
0.06
0.06
0/5
2 Analysts
%
0.86
5/9
$28.75M
$370.68M
$136.6M
-$7.03M
$329.38M
10.04
5.97
6.08
15.80%
12.07%
15.54%
9.79%
$27.95
-437 days
| Name | Title |
|---|---|
| Kenneth Seifert | Treasurer & Chief Financial Officer |
| Robert J. Ruberton | Senior Portfolio Manager of European Credit |
| Joseph Moroney | President & Chief Investment Officer |
| Bret Leas | Portfolio Manager |
| James Vanek | Portfolio Manager |
| James Charles Zelter | Chief Investment Officer of Credit, Managing Partner of Capital Markets. |
| Joseph Daniel Glatt | Chief Legal Officer & Secretary |
No votes yet today — be the first to share your view!
About Apollo Senior Floating Rate Fund Inc. (NYSE:AFT) Stock
The Apollo Senior Floating Rate Fund Inc. is a closed-end mutual fund specializing in fixed income, managed by Apollo Credit Management, LLC. Its core investment strategy centers on senior secured loans, primarily targeting companies with debt rated below investment grade. The fund employs a disciplined and conservative credit selection methodology. This approach places significant emphasis on factors such as strong collateral coverage, structural seniority, and fundamental creditworthiness. Additionally, it prioritizes companies that exhibit leading and defensible market positions, generate consistent positive cash flow, and are led by proven management teams. For performance evaluation, the fund's portfolio is benchmarked against the S&P/LSTA Leveraged Loan Index. Established on February ... 23, 2011, the Apollo Senior Floating Rate Fund Inc. is domiciled in the United States.
FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
2026-06-24 15:00:00
Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCEÂ (palbociclib) in combination with trastuzumab, with or w
Frequently Asked Questions
What is the current Apollo Senior Floating Rate Fund Inc. (AFT) stock price?
Apollo Senior Floating Rate Fund Inc.(NYSE:AFT) stock price is $14.86 in the last trading session. During the trading session, AFT stock reached the peak price of $15.1399 while $12.54 was the lowest point it dropped to. The percentage change in AFT stock occurred in the recent session was --0.34% while the dollar amount for the price change in AFT stock was -$0.05.
AFT's industry and sector of operation?
The NYSE listed AFT is part of Asset Management industry that operates in the broader Financial Services sector.
Who are the executives of AFT?
Kenneth Seifert
| Treasurer & Chief Financial Officer
Robert J. Ruberton
| Senior Portfolio Manager of European Credit
Joseph Moroney
| President & Chief Investment Officer
Bret Leas
| Portfolio Manager
James Vanek
| Portfolio Manager
How many employees does AFT have?
Number of AFT employees currently stands at None. AFT operates from 9 West 57th Street, New York City, NY 10019, US.
Link for AFT official website?
Official Website of AFT is: https://www.agmfunds.com/InvestmentInformation/SeniorFloatingRateFund.aspx
How do I contact AFT?
AFT could be contacted at phone #212-515-3200 and can also be accessed through its website. AFT operates from 9 West 57th Street, New York City, NY 10019, US.
How many shares of AFT are traded daily?
The average number of AFT shares traded daily for last 3 months was 93.72K.
What is the market cap of AFT currently?
The market value of AFT currently stands at $231.42M with its latest stock price at $14.86